A New Treatment for Eye Pressure (Glucoma) | Club75
A new glaucoma therapy procedure based on injecting a protein mixture into the eye has been developed for the treatment of the disease.
An international team of researchers led by Northwestern University School of Medicine has developed a novel strategy to treating glaucoma. Dr. Researchers Benjamin R. Thomson and colleagues have published their findings in the journal Nature Communications.
Image
There are several chambers between the cornea and the lens of the eye that contain a fluid termed eye fluid in human eyes. This fluid is known as ocular fluid. Known as a low-density liquid, it is mostly composed of water and is used for a variety of functions, including shaping the eyeball and preventing dryness of the eyes.
Optic nerve fibers are responsible for the creation and expulsion of ocular fluid, which occurs continuously throughout life. In a healthy person, the rate of generation and release of ocular fluid is the same for both eyes. Glaucoma patients' ocular fluid is not evacuated as soon as it should be in order to prevent further damage. Increased eye pressure, optic nerve damage, and eventually blindness are the result of this condition.
A total of 60 million people around the world are affected by high blood pressure. It is estimated that eye pressure is the leading cause of blindness in persons over the age of sixty. Additionally, there is a type of glaucoma known as "congenital primary glaucoma," which affects newborns between the ages of 0 and 3 years old. Despite the fact that eye drops, medicines, and laser treatments have all been developed to manage high blood pressure, the condition cannot be completely eradicated from the body.
Professor at Northwestern University's Feinberg School of Arts and Sciences. Dr. Susan Quaggin and her students have developed a novel approach to the treatment of glaucoma. In order to develop mice with eye pressure challenges, the researchers used gene editing methods. After injecting a protein combination into the mice's eyes, the researchers attempted to solve the problems caused by genes that were unable to function because their structure had been damaged. As a result, the mice's eyes looked to have returned to their previous state.
Also discovered is that by using this injection method, the beginning of congenital primary ocular pressure can be delayed or prevented altogether. In their experiments with healthy adult mice, the researchers discovered that the pressure in their eyes lowered when they performed the same treatment on them. Therefore, the unique technique can be used to treat adult humans as well, which is a breakthrough.
According to the researchers, the next stage will be to figure out how to transport the protein mixture that will be utilized in the treatment directly into people's eyes.
Reference:
Our eyes are very important and getting the right treatment is never easy. They’re very delicate and as such we should be very cautious with how we deal with them. Thank you for your informative piece on eye treatments.
Thanks so much for this wonderful lesson taught. I would like to read more of this from you.
Wow, that is great to learn this new treatment for glaucoma, I think your research really entails a lot and I encourage everyone to read this.
love it.I would like to read more of this from you.